Estimates of the survival function (a) and kernel estimate of the hazard function (b) with points of greatest decrease. by Iveta Selingerová (849472)

“…<p>Estimates of the survival function (a) and kernel estimate of the hazard function (b) with points of greatest decrease.…”

TPI demalonylation at K56 decreases PPP flux in CDCP1+ CSCs and is indispensable for postchemotherapeutic recurrence. by WenChao Gao (7321640)

Video5_Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex.MOV by Wesam S. Ahmed (10170053)

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a time-dependent manner. by Lan Zhang (90951)

Bacterial intracellular survival increases <i>in vivo</i> persistence in a mouse model of urinary tract infection and decreases antibiotic efficacy. by Cristina Penaranda (433703)

The ketogenic diet causes a significant decrease in insulin, but does not affect the PI3K pathway. by Mai T. Dang (772520)

Three-, bi- and mono-functional Vγ9Vδ2 T-cell subsets decrease in HIV+ patients. by Rita Casetti (608635)

<b>Reduced legacy precipitation decreases microbial community growth efficiency and alters soil organic carbon in a California grassland</b> by Linnea Honeker (13113813)

Trade-offs between suppressing cheaters and decreasing the time to stochastic clearance of a pure producer population, as controlled by <i>K</i>_<i>a</i>, are present for... by Alexander S. Moffett (8250291)

HemaMax administration decreased leukopenia (a) and thrombocytopenia (b) at nadir in irradiated, unsupported rhesus monkeys. by Lena A. Basile (331369)

The long-term impact of sustained exposure-reducing interventions (represented by a decrease in density of female anophelines). by Azra C. Ghani (160248)

Comparison of MAP@0.5 results from experiments. by Junyan Wang (4738518)

“…Additionally, its parameter count and floating-point operations decrease by 6% and 7.9%, respectively. …”

Results of comparison between Model5 and Model9. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

Results of comparison between Model5 and Model10. by Taiga Mori (21410076)

“…We then define the magnitude as the difference between the lowest and highest points of the head within a cycle. In the analysis, we demonstrate that this magnitude varies depending on length and position, thereby providing evidence that nods exhibit a structured pattern. …”

Diagnostic performance of blood parameters to discriminate abnormal from normal MAD activity (A) and decreased from absent MAD activity (B). by Fabrice Rannou (775170)

“…(B) Classifiers for the differentiation of Absent (n = 5) from Decreased (n = 6) MAD activity. 50% PMP: 50% from predicted maximal power (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0132972#sec006" target="_blank">Methods</a>), R: Recovery from exercise, Se: Sensibility, Sp: Specificity, Acc: Accuracy, PPV: Positive predictive value, NPV: Negative predictive value, LR+: Positive likelihood ratio, LR-: Negative likelihood ratio, DOR: Diagnostic odds ratio, NC: Not calculable.…”

Table1_CLEC16A variants conferred a decreased risk to allergic rhinitis in the Chinese population.DOCX by Yongliang Niu (14245295)

“…</p><p>Methods: We applied Agena MassARRAY technology platform to genotype five single nucleotide polymorphisms (SNPs) located in CLEC16A in 1004 controls and 995 cases. …”

Table1_CLEC16A variants conferred a decreased risk to allergic rhinitis in the Chinese population.DOCX by Yongliang Niu (14245295)

“…</p><p>Methods: We applied Agena MassARRAY technology platform to genotype five single nucleotide polymorphisms (SNPs) located in CLEC16A in 1004 controls and 995 cases. …”

MRV decreases the post-therapy viral load set point. by Iart Luca Shytaj (157809)

Transforming growth factor (TGF)-β1 induced a robust decrease in S-phase in non-cancer cell strains by Kimberly A Brown (26546)

“…</p> Human primary cells and human and mouse established cell lines were treated with (TGF-β1) or without (control) 5 ng/ml TGF-β1 for 48 hours. The cells were then harvested and incubated with propidium iodide, and DNA content was determined using a FACS Caliber (Becton-Dickinson). …”

Automated wound healing assay showing decreased motility of IL-4 treated HCAEC. by Tom Skaria (2733439)